Literature DB >> 3115315

Mechanisms of phospholipase C activation: a comparison with the adenylate cyclase system.

G Guillon1, M N Balestre, B Mouillac, R Berrada, C J Kirk.   

Abstract

Many hormones, neurotransmitters or other signaling molecules exert their biological activities through the stimulation of a specific phospholipase C. Once activated, this enzyme hydrolyzes polyphosphoinositide into inositol trisphosphate and diacylglycerol, two products known to regulate the cytosolic calcium concentration and the activity of protein kinase C, respectively. The molecular mechanisms leading to the activation of phospholipase C after the binding of the signal molecule to its specific receptor remain unclear. Yet, recent studies demonstrated that at least three molecules were implicated: the receptor, the phospholipase C and a GTP binding protein. In this review, we have summarized the properties of such systems and, more particularly, those of the vasopressin-sensitive phospholipase C present in WRK1 cells. The existence of many functional and structural analogies for the receptors which regulate adenylate cyclase activity is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115315     DOI: 10.1016/0300-9084(87)90026-5

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

1.  Cholera-toxin and corticotropin modulation of inositol phosphate accumulation induced by vasopressin and angiotensin II in rat glomerulosa cells.

Authors:  G Guillon; N Gallo-Payet; M N Balestre; C Lombard
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

2.  Influence of bacterial toxins and forskolin upon vasopressin-induced inositol phosphate accumulation in WRK 1 cells.

Authors:  G Guillon; M N Balestre; C Lombard; F Rassendren; C J Kirk
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

Review 3.  Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis.

Authors:  Soniya Survase; Melanie E Ivey; Julie Nigro; Narin Osman; Peter J Little
Journal:  Vasc Health Risk Manag       Date:  2005
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.